JAZZ - Jazz Pharmaceuticals plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue1,890,9221,618,6931,487,9731,324,803
Cost of Revenue121,544110,188105,386102,526
Gross Profit1,769,3781,508,5051,382,5871,222,277
Operating Expenses
Research Development222,616196,042160,397133,453
Selling General and Administrative629,330546,556480,092432,747
Non Recurring----
Others----
Total Operating Expenses1,174,9881,004,851847,869766,888
Operating Income or Loss715,934613,842640,104557,915
Income from Continuing Operations
Total Other Income/Expenses Net-188,674-173,734-108,037-121,982
Earnings Before Interest and Taxes715,934613,842640,104557,915
Interest Expense-77,075-77,756-61,942-56,917
Income Before Tax527,260440,108532,067435,933
Income Tax Expense80,162-47,740135,236106,399
Minority Interest----
Net Income From Continuing Ops447,098487,848396,831329,534
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income447,098487,848396,831329,535
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares447,098487,848396,831329,535